Back
Denali Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
18
DNLI
Denali Therapeutics
Last Price:
$20.32
Seasonality Move:
-14.4%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNLI is experiencing selling pressure, which indicates risk of future bearish movement.
Denali Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.4 | Sell |
| 20-day SMA: | 23.04 | Sell |
| 50-day SMA: | 25.37 | Sell |
| 200-day SMA: | 23.05 | Sell |
| 8-day EMA: | 21.48 | Sell |
| 20-day EMA: | 22.78 | Sell |
| 50-day EMA: | 24.48 | Sell |
| 200-day EMA: | 23.98 | Sell |
Denali Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.33 | Sell |
| Relative Strength Index (14 RSI): | 30.74 | Sell |
| Chaikin Money Flow: | -479642 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.83 - 24.89) | Sell |
| Bollinger Bands (100): | (23.11 - 28.65) | Sell |
Denali Therapeutics Technical Analysis
| Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Denali Therapeutics Stock
Is Denali Therapeutics Stock a Buy?
-
Denali Therapeutics share price is 20.61 while DNLI 8-day simple moving average is 21.40, which is a Sell signal.
-
The stock price of DNLI is 20.61 while Denali Therapeutics 20-day SMA is 23.04, which makes it a Sell.
-
Denali Therapeutics 50-day simple moving average is 25.37 while DNLI share price is 20.61, making it a Sell technically.
-
DNLI stock price is 20.61 and Denali Therapeutics 200-day simple moving average is 23.05, creating a Sell signal.
DNLI Technical Analysis vs Fundamental Analysis
Sell
18
Denali Therapeutics (DNLI)
is a Sell
Is Denali Therapeutics a Buy or a Sell?
-
Denali Therapeutics stock is rated a SellThe current Denali Therapeutics [DNLI] share price is $20.61. The Score for DNLI is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Denali Therapeutics Stock Info
Market Cap:
3B
Price in USD:
20.61
Share Volume:
602.2K
Denali Therapeutics 52-Week Range
52-Week High:
33.33
52-Week Low:
14.56
Sell
18
Denali Therapeutics (DNLI)
is a Sell
Denali Therapeutics Share Price Forecast
-
What is the Denali Therapeutics stock price today?The Denali Therapeutics stock price is 20.61 USD today.
-
Will DNLI stock go up or go down?Denali Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Denali Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Denali Therapeutics is overvalued.
Is Denali Therapeutics Stock a Buy?
-
Denali Therapeutics share price is 20.61 while DNLI 8-day exponential moving average is 21.48, which is a Sell signal.
-
The stock price of DNLI is 20.61 while Denali Therapeutics 20-day EMA is 22.78, which makes it a Sell.
-
Denali Therapeutics 50-day exponential moving average is 24.48 while DNLI share price is 20.61, making it a Sell technically.
-
DNLI stock price is 20.61 and Denali Therapeutics 200-day simple moving average is 23.98, creating a Sell signal.
Fundamental Analysis of Denali Therapeutics
Is Denali Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.84 per share, and a decrease next year of $0.15 per share.
Technical Analysis of Denali Therapeutics
Should I short Denali Therapeutics stock?
-
DNLI Moving Average Covergence Divergence (MACD) indicator is -1.33, suggesting Denali Therapeutics is a Sell
-
Denali Therapeutics Relative Strength Index (RSI) is 30.74, which suggest Denali Therapeutics is oversold
-
The Bollinger Bands (25) for Denali Therapeutics is (21.83 - 24.89), which suggest Denali Therapeutics is a Sell
-
The Bollinger Bands (100) for Denali Therapeutics is (23.11 - 28.65), which suggest Denali Therapeutics is a Sell
* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.